Navigation Links
Access MediQuip Moves Company Headquarters to Lake Mary, Florida
Date:11/9/2009

LAKE MARY, Fla., Nov. 9 /PRNewswire/ -- Access MediQuip, LLC, the nation's first and largest provider of outsourced implantable medical device management solutions to the healthcare industry, announced today that it is relocating its corporate headquarters to Lake Mary, Florida. The move, prompted by the firm's continued rapid growth, includes a major expansion of the Primera Blvd, Lake Mary office space that will open in January 2010 and relocation and expansion of the Houston facilities to the new, LEED® certified, One & Two Oak Park complex in the Westchase District.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090310/CG80801LOGO)

"Our growth is fueled by success in helping our clients reduce healthcare costs and improve patient care," said Access MediQuip Chief Executive Officer Tim Hargarten. "Access MediQuip is pleased to be able to continue supporting job growth and further economic development in the greater Orlando and Houston markets."

Access MediQuip was founded in 1997 to bring clarity and efficiency to the procurement, reimbursement and management of high-cost implantable medical devices such as orthopedic and spinal implants. Since that time, Access MediQuip has become the nation's leading provider of implantable medical device management solutions. The company has expanded its services to more than 2,500 healthcare payers and providers, and 175 device manufacturers to help manage implantable medical devices used for thousands of procedures. Access MediQuip has also developed the industry's largest database of claims information for implantable medical devices to provide payers, manufacturers and providers with the most comprehensive data available on U.S. implantable medical device costs and utilization rates.

"Our expanded Houston facilities will capitalize on the outstanding business environment, infrastructure and healthcare resources that propelled our growth in the last several years," says Bill Elliott, Access MediQuip President and COO. "In addition to its pro-business climate, the Lake Mary area offers a talent pool with deep experience in specialty managed care that will facilitate our ability to attract the quality human resources we will need to achieve our vision."

Access MediQuip is the nation's first and largest provider of outsourced implantable medical device management solutions. The company works with thousands of payers, manufacturers and providers to manage the acquisition, financing, delivery and reimbursement of implantable medical devices such as orthopedic and spinal implants. Founded in 1997, the company is now headquartered in Lake Mary, Florida. For more information, please visit www.accessmediquip.com.

SOURCE Access MediQuip, LLC


'/>"/>
SOURCE Access MediQuip, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 2017 Summary ... as a Key Component of Multichannel Marketing" provides ... landscape in the digital age. While the ... medical advancements, it has been much slower to ... on traditional channels and methods. However, the decreasing ...
(Date:3/28/2017)... , March 29, 2017 Center ... Siteless CRO platform, announced today study results presented ... Care Pharmacy, #AMCP2017, Managed Care and Specialty Pharmacy ... . Data in both posters demonstrated that pharmacist-led patient ... protocol adherence. These factors are crucial to generating the ...
(Date:3/28/2017)... CAMBRIDGE , United Kingdom and  BOSTON ... text analytics provider Linguamatics today announced ... Dow Jones . The agreement allows pharmaceutical companies ... utilizing Linguamatics I2E text mining technology. ... used by 18 of the top 20 global ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a leading developer ... Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to ... with efforts by the American College of Surgeons, U.S. Department of Defense, Department ...
(Date:3/28/2017)... ... 28, 2017 , ... Award-winning medical group Allied Anesthesia today ... board chair for Orange County health care system CalOptima Friday. CalOptima announced its ... chair Mark Refowitz’s term, which runs through June 30 of this year, until ...
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon ... and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list of ...
(Date:3/28/2017)... ... ... Oily skin is a common and unwelcomed occurrence in people of all ages, genders and ... to the discussion of dealing with excess skin oil. “Oily skin is a challenge to ... can help remove the oily shine while keeping the skin fresh and clean,” says Dr. ...
Breaking Medicine News(10 mins):